Samsung Biologics
207940.KS
#388
Rank
C$74.10 B
Marketcap
$1,041
Share price
-2.41%
Change (1 day)
20.40%
Change (1 year)

EPS for Samsung Biologics (207940.KS)

EPS in 2023 (TTM): $12.08

According to Samsung Biologics 's latest financial reports the company's current EPS (TTM) is $12.86. In 2022 the company made an earnings per share (EPS) of $12.86 an increase over its 2021 EPS that were of $7.30.

EPS history for Samsung Biologics from 2016 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$12.08-6.08%
2022$12.8676.23%
2021$7.3061.48%
2020$4.5221.05%
2019$3.73-12.56%
2018$4.27-330.46%
2017-$1.85-51.86%
2016-$3.85